BlastX
Device Wound Care
General payments
$896,841
Research payments
$660,931
Through program year 2022, $896,841 in general payments and $660,931 in research payments were reported against BlastX (Wound Care).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $433,728 | 910 |
| 2022 | Research | $28,250 | 2 |
| 2021 | General | $328,897 | 5 |
| 2021 | Research | $185,156 | 36 |
| 2020 | General | $134,215 | 20 |
| 2020 | Research | $317,088 | 75 |
| 2019 | Research | $130,437 | 13 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 50 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 38 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
935 general · 126 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.